Evidence map›Paper›PMID 26059841›Full record

ArticleEuropean journal of human genetics : EJHG2016

Exon skipping causes atypical phenotypes associated with a loss-of-function mutation in FLNA by restoring its protein function.

Hirotsugu Oda, Tatsuhiro Sato, Shinji Kunishima, Kenji Nakagawa, Kazushi Izawa, Eitaro Hiejima, Tomoki Kawai, Takahiro Yasumi, Hiraku Doi, Kenji Katamura and 12 more

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in European journal of human genetics : EJHG, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Bone reports · 2023
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Visceral myopathy: clinical syndromes, genetics, pathophysiology, and fall of the cytoskeleton.American journal of physiology. Gastrointestinal and liver physiology · 2021
    Review
  13. Article
  14. Article
  15. Rgma-Induced Neo1 Proteolysis Promotes Neural Tube Morphogenesis.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2019
    Article
  16. Article
  17. Reply to Walsh et al.European journal of human genetics : EJHG · 2017
    Article
  18. Update on a previously reported male with a FLNA missense mutation.European journal of human genetics : EJHG · 2017
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors at 9 institutions in 1 country.

Hirotsugu OdaDepartment of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Tatsuhiro SatoDivision of Biochemistry, School of Pharmaceutical Science, Kitasato University, Tokyo, Japan.
Shinji KunishimaDepartment of Advanced Diagnosis, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
Kenji NakagawaDepartment of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Kazushi IzawaDepartment of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Eitaro HiejimaDepartment of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Tomoki KawaiDepartment of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Takahiro YasumiDepartment of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Hiraku DoiDepartment of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Kenji KatamuraDepartment of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Hironao NumabeDepartment of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Shinya OkamotoDepartment of Surgery (Hepato-Biliary-Pancreatic and Transplantation), Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Hiroshi NakaseDepartment of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Atsushi HijikataLaboratory for Integrative Genomics, RIKEN Center for Integrative Medical Sciences (RIKEN-IMS), Yokohama, Japan.
Osamu OharaLaboratory for Integrative Genomics, RIKEN Center for Integrative Medical Sciences (RIKEN-IMS), Yokohama, Japan.
Hidenori SuzukiDepartment of Morphological and Biomolecular Research, Nippon Medical School, Tokyo, Japan.
Hiroko MorisakiDepartment of Bioscience and Genetics, National Cerebral and Cardiovascular Center Research Institute, Osaka, Japan.
Takayuki MorisakiDepartment of Bioscience and Genetics, National Cerebral and Cardiovascular Center Research Institute, Osaka, Japan.
Hiroyuki NunoiDivision of Pediatrics, Department of Reproductive and Developmental Medicine, University of Miyazaki, Miyazaki, Japan.
Seisuke HattoriDivision of Biochemistry, School of Pharmaceutical Science, Kitasato University, Tokyo, Japan.
Ryuta NishikomoriDepartment of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Toshio HeikeDepartment of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Kyoto University · JPKitasato University · JPNational Cerebral and Cardiovascular Center · JPRIKEN Center for Integrative Medical Sciences · JPKazusa DNA Research Institute · JPNational Hospital Organization · JPNippon Medical School · JPOchanomizu University · JPUniversity of Miyazaki · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Loss-of-function mutations in filamin A (FLNA) cause an X-linked dominant disorder with multiple organ involvement. Affected females present with periventricular nodular heterotopia (PVNH), cardiovascular complications, thrombocytopenia and Ehlers-Danlos syndrome. These mutations are typically lethal to males, and rare male survivors suffer from failure to thrive, PVNH, and severe cardiovascular and gastrointestinal complications. Here we report two surviving male siblings with a loss-of-function mutation in FLNA. They presented with multiple complications, including valvulopathy, intestinal malrotation and chronic intestinal pseudo-obstruction (CIPO). However, these siblings had atypical clinical courses, such as a lack of PVNH and a spontaneous improvement of CIPO. Trio-based whole-exome sequencing revealed a 4-bp deletion in exon 40 that was predicted to cause a lethal premature protein truncation. However, molecular investigations revealed that the mutation induced in-frame skipping of the mutated exon, which led to the translation of a mutant FLNA missing an internal region of 41 amino acids. Functional analyses of the mutant protein suggested that its binding affinity to integrin, as well as its capacity to induce focal adhesions, were comparable to those of the wild-type protein. These results suggested that exon skipping of FLNA partially restored its protein function, which could contribute to amelioration of the siblings' clinical courses. This study expands the diversity of the phenotypes associated with loss-of-function mutations in FLNA.

Indexed as

AdultBlood CellsChildChild, PreschoolExonsFemaleFilaminsFluorescent Antibody TechniqueHEK293 CellsHumansInfantInfant, NewbornMaleMutationPedigreePhenotypeFilamins

Identifiers

PMID26059841
PMCPMC4755370
OpenAlexW1546526195

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.